Other headlinesNovel PET agent begins testingSiemens DR buoys charity
Merge unveils next gen web portal
Merge Healthcare unveiled today a zero-client software platform, FusionWeb, that promises to allow easy access by referring physicians to patient information, procedure reports and digital images. With FusionWeb, hospitals and imaging centers can include diagnostic images as part of a patient’s electronic medical record regardless of browser type, operating platform or security policies. The zero client software works without the need to install or maintain special visualization devices or software plug-ins. Anyone with a secured logon can access work lists and images, according to Merge. The new platform is based on Merge’s Cedara WebAccess technology. It can be bundled with the company’s Fusion RIS and PACS products.
Novel PET agent begins testing
Lantheus Medical Imaging has begun a Phase 1 clinical study to assess the safety, dosimetry, and tolerability of a novel PET radiotracer designed to identify patients at risk of fatal arrhythmia. The F-18 agent, dubbed LMI1195, is designed to visually indicate cardiac neuronal function. Done on healthy subjects, the Phase 1 study will attempt to estimate the radiation dosimetry of LMI1195, as well as evaluate the safety and patient tolerability of the tracer. Investigators will also gather pharmacokinetic and metabolic data, and assess PET imaging parameters and image quality.
Siemens DR buoys charity
Siemens’ donation of a digital radiography system has put $285,000 in the coffers of the Children’s Health Fund. Siemens donated a new Ysio to the Fund, which ran an online auction won by John T. Mather Memorial Hospital. The Port Jefferson, NY, hospital this week presented a check for its winning bid to the national organization dedicated to provide health care for homeless and medically disadvantaged children and advocating on behalf of all children.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.